Project 3: Human Fetal Lung, Arsenic Exposure, Tissue Remodeling
项目 3:人类胎儿肺、砷暴露、组织重塑
基本信息
- 批准号:8208763
- 负责人:
- 金额:$ 4.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AdultAdverse effectsAffectAirArsenicAsthmaBiological MarkersBloodBronchiectasisChildChildhoodChronicCoughingDevelopmentDiseaseDistalDrug KineticsDyspneaEnsureEnvironmental ExposureEnvironmental ImpactEpigenetic ProcessEpitheliumEquilibriumEtiologyEvaluationExposure toFetal DevelopmentFetal LungGasesGene ExpressionGoalsGraft SurvivalGrowthHumanIncidenceKineticsLeadLinkLungLung diseasesMalignant neoplasm of lungMediatingModelingModificationMolecularMolecular TargetMorbidity - disease rateMusPhenotypePilot ProjectsPregnancyRoleSiteStagingSystemTestingTissuesToxic Environmental SubstancesWorkXenograft ModelXenograft proceduredrinking waterexposed human populationin uteroinsightlung developmentlung maturationlung xenograftneoplasticnoveloffspringpostnatalrespiratoryyoung adult
项目摘要
Fetal lung development requires coordinated remodeling of pulmonary epithelium, vasculature and
supporting matrix to establish an effective gas exchange system. Intrauterine and early postnatal
exposure to environmental toxicants may disrupt this delicate balance and result in respiratory morbidity
in children and adults. Inorganic arsenic is a ubiquitous environmental toxicant that targets the lung with
both neoplastic and non-neoplastic endpoints. Recent evidence in mice suggests that gestational
exposure to arsenic disrupts fetal lung development and results in an asthma-like phenotype in the
offspring. Studies in humans described increased incidence of bronchiectasis, dyspnea, chronic
obstructive and restrictive lung disease in children and young adults exposed to arsenic in utero. This
pilot project will develop and employ a human fetal lung xenograft model to determine the mechanisms
of arsenic-induced disruption of human fetal lung remodeling. Our central hypothesis is: Arsenic
exposure of human fetal lung xenotransplants results in disrupted postglandular lung remodeling,
mediated by molecular and epigenetic alterations. We will perform xenotransplants of 2nd trimester
human fetal lungs, allowing study of human lung maturation and cytodifferentiation from pseudoglandular
and canalicular stages of development. In Specific Aim 1. we will develop a human fetal lung xenograft
model of in utero arsenic exposure. We will assess the best graft conditions, including size, site and
initial stage to ensure optimal graft survival and maturation. In addition. we will study the
pharmacokinetic relationship between arsenic exposure in the drinking water and tissue-specific
distribution of arsenic and its metabolites. In Specific Aim 2. we will determine the effects of
environmentally relevant levels of arsenic exposure on growth kinetics. cytodifferentiation and global
gene expression in the developing human lung. Finally, in Specific Aim 3. we will determine the
epigenetic modifications induced by arsenic exposure in the human xenografts. This pilot project will lead
to the elucidation of molecular targets and biomarkers of inorganic arsenic exposure during lung
development and may give insight into the etiology of arsenic-induced respiratory disease and lung
cancers.
胎儿肺发育需要肺上皮、血管和肺组织的协调重塑。
支持矩阵建立有效的气体交换系统。宫内和产后早期
暴露于环境毒物可能会破坏这种微妙的平衡,并导致呼吸道疾病
儿童和成人。无机砷是一种普遍存在的环境毒物,
肿瘤性和非肿瘤性终点。最近在小鼠身上的证据表明,妊娠期
暴露于砷会破坏胎儿肺发育,并导致哮喘样表型,
后代人类研究描述了支气管扩张、呼吸困难、慢性
在子宫内接触砷的儿童和年轻人的阻塞性和限制性肺病。这
试点项目将开发和使用人胎肺异种移植模型,以确定机制
砷诱导的人类胎儿肺重塑的破坏。我们的核心假设是:砷
暴露于人胎儿肺异种移植物导致腺后肺重塑被破坏,
由分子和表观遗传改变介导。我们将进行第二个三个月的异种移植
人胎肺,允许研究人肺成熟和假腺细胞分化
和发育的小管阶段。具体目标1。我们将开发一种人类胚胎肺异种移植
宫内砷暴露模型。我们将评估最佳的移植条件,包括大小,位置和
初始阶段,以确保最佳的移植物存活和成熟。另外。我们会研究
饮水砷暴露与组织特异性代谢的药代动力学关系
砷及其代谢产物的分布。具体目标2。我们将确定
环境相关水平的砷暴露对生长动力学的影响。细胞分化和整体
基因在人类肺发育中的表达。第三,具体目标。康贝特人将以
人类异种移植物中砷暴露诱导的表观遗传修饰。该试点项目将引领
阐明无机砷暴露的分子靶点和生物标志物,
发展,并可能深入了解砷引起的呼吸道疾病和肺
癌的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MONIQUE E DEPAEPE其他文献
MONIQUE E DEPAEPE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MONIQUE E DEPAEPE', 18)}}的其他基金
Project 3: Human Fetal Lung, Arsenic Exposure, Tissue Remodeling
项目 3:人类胎儿肺、砷暴露、组织重塑
- 批准号:
7846632 - 财政年份:2010
- 资助金额:
$ 4.46万 - 项目类别:
COBRE: W & I HOSP OF RI: FAS-MEDIATED APOPTOSIS IN PERINATAL LUNG REMODELING
铜芯:W
- 批准号:
7720724 - 财政年份:2008
- 资助金额:
$ 4.46万 - 项目类别:
COBRE: W & I HOSP OF RI: FAS-MEDIATED APOPTOSIS IN PERINATAL LUNG REMODELING
铜芯:W
- 批准号:
7610526 - 财政年份:2007
- 资助金额:
$ 4.46万 - 项目类别:
COBRE: W & I HOSP OF RI: FAS-MEDIATED APOPTOSIS IN PERINATAL LUNG REMODELING
铜芯:W
- 批准号:
7381993 - 财政年份:2006
- 资助金额:
$ 4.46万 - 项目类别:
COBRE: W & I HOSP OF RI: FAS-MEDIATED APOPTOSIS IN PERINATAL LUNG REMODELING
铜芯:W
- 批准号:
7171214 - 财政年份:2005
- 资助金额:
$ 4.46万 - 项目类别:
COBRE: W & I HOSP OF RI: FAS-MEDIATED APOPTOSIS IN PERINATAL LUNG REMODELING
铜芯:W
- 批准号:
6981889 - 财政年份:2004
- 资助金额:
$ 4.46万 - 项目类别:
Project 3: Human Fetal Lung, Arsenic Exposure, Tissue Remodeling
项目 3:人类胎儿肺、砷暴露、组织重塑
- 批准号:
8375006 - 财政年份:
- 资助金额:
$ 4.46万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 4.46万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 4.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 4.46万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 4.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 4.46万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 4.46万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 4.46万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 4.46万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 4.46万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 4.46万 - 项目类别:
Studentship